ENANTA PHARMACEUTICALS, INC Financing Cash Flow
ENANTA PHARMACEUTICALS, INC (ENTA) reported Financing Cash Flow of $51.30 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-12
- ENANTA PHARMACEUTICALS, INC net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$5.54M.
- ENANTA PHARMACEUTICALS, INC net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$7.29M.
- ENANTA PHARMACEUTICALS, INC net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $64.14M.
- ENANTA PHARMACEUTICALS, INC net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$8.32M.
- ENANTA PHARMACEUTICALS, INC net cash provided by (used in) financing activities for fiscal 2025 was -$26.62M.
- ENANTA PHARMACEUTICALS, INC net cash provided by (used in) financing activities for fiscal 2024 was -$27.63M, a 113.94% decline from fiscal 2023.
- ENANTA PHARMACEUTICALS, INC net cash provided by (used in) financing activities for fiscal 2023 was $198.13M, a 889.00% increase from fiscal 2022.
- ENANTA PHARMACEUTICALS, INC net cash provided by (used in) financing activities for fiscal 2022 was $20.03M, a 550.42% increase from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$5.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-12 | -$12.84M derived: sum of 2 quarters · filed 2026-08-12 | $51.30M 10-Q · filed 2026-08-12 | $42.98M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | -$7.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-13 | $56.84M 10-Q · filed 2026-05-13 | $48.52M derived: sum of 3 quarters · filed 2026-05-13 | $42.10M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $64.14M 10-Q · filed 2026-02-11 | $55.81M derived: sum of 2 quarters · filed 2026-02-11 | $49.39M derived: sum of 3 quarters · filed 2026-08-12 | $42.50M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-09-30 | -$8.32M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-19 | -$14.74M derived: sum of 2 quarters · filed 2026-08-12 | -$21.63M derived: sum of 3 quarters · filed 2026-08-12 | -$26.62M 10-K · filed 2025-11-19 |
| 2025-06-30 | -$6.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-12 | -$13.31M derived: sum of 2 quarters · filed 2026-08-12 | -$18.30M 10-Q · filed 2026-08-12 | -$25.51M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | -$6.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-13 | -$11.87M 10-Q · filed 2026-05-13 | -$19.09M derived: sum of 3 quarters · filed 2026-05-13 | -$25.73M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | -$4.99M 10-Q · filed 2026-02-11 | -$12.20M derived: sum of 2 quarters · filed 2026-02-11 | -$18.85M derived: sum of 3 quarters · filed 2026-02-11 | -$25.26M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-09-30 | -$7.21M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-19 | -$13.86M derived: sum of 2 quarters · filed 2025-11-19 | -$20.28M derived: sum of 3 quarters · filed 2025-11-19 | -$27.63M 10-K · filed 2025-11-19 |
| 2024-06-30 | -$6.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-13 | -$13.06M derived: sum of 2 quarters · filed 2025-08-13 | -$20.41M 10-Q · filed 2025-08-13 | -$20.43M derived: sum of 4 quarters · filed 2025-11-19 |
| 2024-03-31 | -$6.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-14 | -$13.76M 10-Q · filed 2025-05-14 | -$13.79M derived: sum of 3 quarters · filed 2025-11-19 | $186.09M derived: sum of 4 quarters · filed 2025-11-19 |
| 2023-12-31 | -$7.35M 10-Q · filed 2025-02-12 | -$7.37M derived: sum of 2 quarters · filed 2025-11-19 | $192.50M derived: sum of 3 quarters · filed 2025-11-19 | $190.47M derived: sum of 4 quarters · filed 2025-11-19 |
| 2023-09-30 | -$23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-19 | $199.85M derived: sum of 2 quarters · filed 2025-11-19 | $197.82M derived: sum of 3 quarters · filed 2025-11-19 | $198.13M 10-K · filed 2025-11-19 |
| 2023-06-30 | $199.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-07 | $197.85M derived: sum of 2 quarters · filed 2024-08-07 | $198.15M 10-Q · filed 2024-08-07 | $201.08M derived: sum of 4 quarters · filed 2024-11-27 |
| 2023-03-31 | -$2.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-08 | -$1.73M 10-Q · filed 2024-05-08 | $1.20M derived: sum of 3 quarters · filed 2024-11-27 | $5.32M derived: sum of 4 quarters · filed 2024-11-27 |
| 2022-12-31 | $301.00K 10-Q · filed 2024-02-08 | $3.23M derived: sum of 2 quarters · filed 2024-11-27 | $7.35M derived: sum of 3 quarters · filed 2024-11-27 | $10.70M derived: sum of 4 quarters · filed 2024-11-27 |
| 2022-09-30 | $2.93M derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-27 | $7.05M derived: sum of 2 quarters · filed 2024-11-27 | $10.40M derived: sum of 3 quarters · filed 2024-11-27 | $20.03M 10-K · filed 2024-11-27 |
| 2022-06-30 | $4.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-08 | $7.47M derived: sum of 2 quarters · filed 2023-08-08 | $17.10M 10-Q · filed 2023-08-08 | $18.05M derived: sum of 4 quarters · filed 2023-11-22 |
| 2022-03-31 | $3.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-09 | $12.98M 10-Q · filed 2023-05-09 | $13.93M derived: sum of 3 quarters · filed 2023-11-22 | $14.61M derived: sum of 4 quarters · filed 2023-11-22 |
| 2021-12-31 | $9.63M 10-Q · filed 2023-02-08 | $10.57M derived: sum of 2 quarters · filed 2023-11-22 | $11.26M derived: sum of 3 quarters · filed 2023-11-22 | $12.41M derived: sum of 4 quarters · filed 2023-11-22 |
| 2021-09-30 | $943.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-22 | $1.63M derived: sum of 2 quarters · filed 2023-11-22 | $2.78M derived: sum of 3 quarters · filed 2023-11-22 | $3.08M 10-K · filed 2023-11-22 |
| 2021-06-30 | $686.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-08 | $1.84M derived: sum of 2 quarters · filed 2022-08-08 | $2.14M 10-Q · filed 2022-08-08 | $2.37M derived: sum of 4 quarters · filed 2022-11-23 |
| 2021-03-31 | $1.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-09 | $1.45M 10-Q · filed 2022-05-09 | $1.68M derived: sum of 3 quarters · filed 2022-11-23 | $4.91M derived: sum of 4 quarters · filed 2022-11-23 |
| 2020-12-31 | $299.00K 10-Q · filed 2022-02-10 | $532.00K derived: sum of 2 quarters · filed 2022-11-23 | $3.76M derived: sum of 3 quarters · filed 2022-11-23 | $8.12M derived: sum of 4 quarters · filed 2022-11-23 |
| 2020-09-30 | $233.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-23 | $3.46M derived: sum of 2 quarters · filed 2022-11-23 | $7.82M derived: sum of 3 quarters · filed 2022-11-23 | $8.98M 10-K · filed 2022-11-23 |
| 2020-06-30 | $3.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-09 | $7.58M derived: sum of 2 quarters · filed 2021-08-09 | $8.75M 10-Q · filed 2021-08-09 | $9.44M derived: sum of 4 quarters · filed 2021-11-24 |
| 2020-03-31 | $4.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-10 | $5.52M 10-Q · filed 2021-05-10 | $6.21M derived: sum of 3 quarters · filed 2021-11-24 | $6.70M derived: sum of 4 quarters · filed 2021-11-24 |
| 2019-12-31 | $1.17M 10-Q · filed 2021-02-09 | $1.85M derived: sum of 2 quarters · filed 2021-11-24 | $2.34M derived: sum of 3 quarters · filed 2021-11-24 | $2.60M derived: sum of 4 quarters · filed 2021-11-24 |
| 2019-09-30 | $687.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-24 | $1.18M derived: sum of 2 quarters · filed 2021-11-24 | $1.43M derived: sum of 3 quarters · filed 2021-11-24 | $2.57M 10-K · filed 2021-11-24 |
| 2019-06-30 | $490.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-10 | $747.00K derived: sum of 2 quarters · filed 2020-08-10 | $1.89M 10-Q · filed 2020-08-10 | $2.92M derived: sum of 4 quarters · filed 2020-11-25 |
| 2019-03-31 | $257.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-11 | $1.40M 10-Q · filed 2020-05-11 | $2.43M derived: sum of 3 quarters · filed 2020-11-25 | $5.39M derived: sum of 4 quarters · filed 2020-11-25 |
| 2018-12-31 | $1.14M 10-Q · filed 2020-02-10 | $2.17M derived: sum of 2 quarters · filed 2020-11-25 | $5.14M derived: sum of 3 quarters · filed 2020-11-25 | $5.13M derived: sum of 4 quarters · filed 2020-11-25 |
| 2018-09-30 | $1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-25 | $4.00M derived: sum of 2 quarters · filed 2020-11-25 | $3.99M derived: sum of 3 quarters · filed 2020-11-25 | $4.41M 10-K · filed 2020-11-25 |
| 2018-06-30 | $2.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-09 | $2.96M derived: sum of 2 quarters · filed 2019-08-09 | $3.38M 10-Q · filed 2019-08-09 | $4.38M derived: sum of 4 quarters · filed 2019-11-27 |
| 2018-03-31 | -$6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-10 | $411.00K 10-Q · filed 2019-05-10 | $1.42M derived: sum of 3 quarters · filed 2019-11-27 | |
| 2017-12-31 | $417.00K 10-Q · filed 2019-02-08 | $1.42M derived: sum of 2 quarters · filed 2019-11-27 | ||
| 2017-09-30 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-27 | $1.02M 10-K · filed 2019-11-27 | ||
| 2017-06-30 | $10.00K 10-Q · filed 2018-08-09 | |||
| 2016-09-30 | $2.71M 10-K · filed 2018-11-29 | |||
| 2014-03-31 | $557.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-12 | $646.00K 10-Q · filed 2014-05-12 | $768.00K derived: sum of 3 quarters · filed 2014-05-12 | -$677.00K derived: sum of 4 quarters · filed 2014-05-12 |
| 2013-12-31 | $89.00K 10-Q · filed 2014-02-13 | $211.00K derived: sum of 2 quarters · filed 2014-02-13 | -$1.23M derived: sum of 3 quarters · filed 2014-02-13 | $58.32M derived: sum of 4 quarters · filed 2014-05-12 |
| 2013-09-30 | $122.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-18 | -$1.32M derived: sum of 2 quarters · filed 2013-12-18 | $58.23M derived: sum of 3 quarters · filed 2014-05-12 | $56.91M 10-K · filed 2013-12-18 |
| 2013-06-30 | -$1.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-12 | $58.11M derived: sum of 2 quarters · filed 2014-05-12 | $56.79M 10-Q · filed 2013-08-12 | $55.80M derived: sum of 4 quarters · filed 2014-05-12 |
| 2013-03-31 | $59.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-12 | $58.23M 10-Q · filed 2014-05-12 | $57.24M derived: sum of 3 quarters · filed 2014-05-12 | $57.22M derived: sum of 4 quarters · filed 2014-05-12 |
| 2012-12-31 | -$1.32M 10-Q · filed 2014-02-13 | -$2.31M derived: sum of 2 quarters · filed 2014-02-13 | -$2.34M derived: sum of 3 quarters · filed 2014-02-13 | |
| 2012-09-30 | -$991.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-18 | -$1.02M derived: sum of 2 quarters · filed 2013-12-18 | -$909.00K 10-K · filed 2013-12-18 | |
| 2012-06-30 | -$25.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-12 | $82.00K 10-Q · filed 2013-08-12 | ||
| 2012-03-31 | $107.00K 10-Q · filed 2013-05-15 | |||
| 2011-09-30 | $34.00K 10-K · filed 2013-12-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |